Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$700M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$344M |
| 3 |
NVIDIA
NVDA
|
$217M |
| 4 |
Emerson Electric
EMR
|
$177M |
| 5 |
Apple
AAPL
|
$169M |
Top Sells
| 1 |
Expedia Group
EXPE
|
$142M |
| 2 |
Wynn Resorts
WYNN
|
$141M |
| 3 |
Blackrock
BLK
|
$135M |
| 4 |
Haleon
HLN
|
$126M |
| 5 |
Intuit
INTU
|
$116M |
Sector Composition
| 1 | Technology | 30.36% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 9.06% |
| 5 | Industrials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
D.R. Horton
DHI
$54.2B
| $33.3M | 0.01% |
237,959
+5,327
| +2% | +$745K |
|
277
Cavco Industries
CVCO
$4.32B
| $32.8M | 0.01% |
73,511
+2,024
| +3% | +$903K |
|
278
UMB Financial
UMBF
$9.45B
| $32.8M | 0.01% |
290,326
+29,516
| +11% | +$3.33M |
|
279
Nucor
NUE
$33.8B
| $32.6M | 0.01% |
279,183
+64,980
| +30% | +$7.58M |
|
280
Cleveland-Cliffs
CLF
$5.63B
| $32.2M | 0.01% |
3,424,514
-2,024,607
| -37% | -$19M |
|
281
First American
FAF
$6.83B
| $32.1M | 0.01% |
514,483
-37,006
| -7% | -$2.31M |
|
282
Baker Hughes
BKR
$44.9B
| $32.1M | 0.01% |
782,884
-53,272
| -6% | -$2.19M |
|
283
Delek US
DK
$1.88B
| $31.9M | 0.01% |
1,726,405
-64,675
| -4% | -$1.2M |
|
284
Cactus
WHD
$2.93B
| $31.9M | 0.01% |
546,987
+216,543
| +66% | +$12.6M |
|
285
Steven Madden
SHOO
$2.2B
| $31.7M | 0.01% |
745,798
+17,124
| +2% | +$728K |
|
286
Agios Pharmaceuticals
AGIO
$2.09B
| $31.6M | 0.01% |
960,661
+105,333
| +12% | +$3.46M |
|
287
FIVE9
FIVN
$2.06B
| $30.9M | 0.01% |
760,308
-1,658
| -0.2% | -$67.4K |
|
288
Occidental Petroleum
OXY
$45.2B
| $30.3M | 0.01% |
613,647
+6,461
| +1% | +$319K |
|
289
Veeco
VECO
$1.47B
| $29.7M | 0.01% |
1,106,888
+137,194
| +14% | +$3.68M |
|
290
Tetra Tech
TTEK
$9.48B
| $29.2M | 0.01% |
732,021
-5,373
| -0.7% | -$214K |
|
291
Cytokinetics
CYTK
$6.34B
| $29M | 0.01% |
616,492
+74,208
| +14% | +$3.49M |
|
292
Affiliated Managers Group
AMG
$6.54B
| $28.9M | 0.01% |
156,210
+71,458
| +84% | +$13.2M |
|
293
APA Corp
APA
$8.14B
| $28.8M | 0.01% |
1,248,274
+225,726
| +22% | +$5.21M |
|
294
Ovintiv
OVV
$10.6B
| $28.6M | 0.01% |
707,351
-32,659
| -4% | -$1.32M |
|
295
Crinetics Pharmaceuticals
CRNX
$3.35B
| $28.6M | 0.01% |
559,287
+77,188
| +16% | +$3.95M |
|
296
CONMED
CNMD
$1.7B
| $28.6M | 0.01% |
417,430
+122,140
| +41% | +$8.36M |
|
297
Diageo
DEO
$61.3B
| $28.4M | 0.01% |
223,767
-822
| -0.4% | -$105K |
|
298
The Greenbrier Companies
GBX
$1.46B
| $28.4M | 0.01% |
466,053
-34,236
| -7% | -$2.09M |
|
299
Cal-Maine
CALM
$5.52B
| $28.4M | 0.01% |
275,664
+9,345
| +4% | +$962K |
|
300
Granite Construction
GVA
$4.73B
| $28.3M | 0.01% |
322,124
-41,692
| -11% | -$3.66M |
|